Roche Holding AG (OTCQX International Premier:RHHVF)

319.25
Delayed Data
As of Dec 01
 -8.65 / -2.64%
Today’s Change
299.01
Today|||52-Week Range
430.00
-21.40%
Year-to-Date
Lilly's (LLY) Donanemab Betters Biogen's Alzheimer's Drug
Dec 01 / Zacks.com - Paid Partner Content
Here's What's Driving AbbVie's (ABBV) Outperformance This Year
Nov 28 / Zacks.com - Paid Partner Content
Biogen's (BIIB) Lecanemab Shows Benefit but With Side Effects
Nov 30 / Zacks.com - Paid Partner Content
Halozyme (HALO) Stock Rises 35% in the Year so Far: Here's Why
Nov 25 / Zacks.com - Paid Partner Content
Biogen (BIIB) Down on Report of Death in Alzheimer's Study
Nov 29 / Zacks.com - Paid Partner Content
Novartis (NVS) Set to Advance Malaria Drug Into Phase III
Nov 24 / Zacks.com - Paid Partner Content
Sarepta's (SRPT) DMD Gene Therapy BLA Gets FDA Priority Review
Nov 29 / Zacks.com - Paid Partner Content